Products

Clair – The AI Clinical Reference Tool
Clair
Clinical Decision Support & Reference
Clair is an AI clinical reference tool that provides healthcare teams with accurate, real-time answers to clinical questions, streamlining decisions on disease states, treatments, and drug interactions.

See all 1 product →

About Clair

Clair Health is an innovative healthcare AI company dedicated to revolutionizing women’s health through its pioneering non-invasive continuous hormone tracker. The company leverages advanced sensor fusion and deep learning models, trained on diverse female physiology, to continuously monitor key reproductive hormones such as estrogen, progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) via a wrist-worn device. This technology aims to provide real-time hormonal insights and personalized information, empowering women to better understand their bodies, advocate for their health with evidence, and transition towards more proactive, preventative healthcare approaches.

The device integrates 10 biosensors, including skin temperature, resting heart rate, heart rate variability, sleep architecture, breathing rate, electrodermal activity, and motion tracking, correlating these signals with hormonal fluctuations throughout the menstrual cycle. Clair Health’s focus areas encompass fertility tracking, enabling confirmation of ovulation and identification of fertile windows; hormonal health management, to understand the impact of hormones on mood, energy, and sleep; optimization of athletic performance; and comprehensive support during perimenopause and menopause. The company plans to seek FDA approval to establish its device as a medically credible tool, with an app beta launch anticipated in February 2026 and hardware release slated for late 2026.

Focus Areas

Women's health continuous hormone monitoring fertility tracking hormonal health management athletic performance perimenopause menopause cycle irregularity PCOS skin health mood changes

Business Intelligence

TechnologyAI, deep learning models, advanced sensor fusion, 10 biosensors (skin temperature, resting heart rate, HRV, breath rate, electrodermal activity, motion tracking), 100+ proprietary biomarkers, in-house female biology world model, on-device AI processing

What Physicians Need to Know

Continuous Hormone Monitoring
Clair offers the first non-invasive, wrist-worn wearable that continuously tracks key reproductive hormones including estrogen, progesterone, LH, FSH, and PdG in real-time, moving beyond episodic snapshots from blood draws or urine sticks.
Fertility Tracking & Cycle Irregularity
Provides continuous, data-driven insights into cycle patterns and ovulation timing, highly accurate even for irregular cycles or conditions like PCOS, as it monitors actual physiological signals rather than relying on calendar-based predictions.
Hormonal Health Management
Enables users to identify hormonal patterns and changes across their cycle to better understand symptoms, balance, and overall well-being, positioning hormones as a foundational health signal throughout the female lifespan.
Athletic Performance Optimization
Helps align training, recovery, and daily movement with an individual's hormonal cycle to optimize energy, performance, and resilience, by also capturing sleep, recovery, daily activity, heart rate, and HRV.
Perimenopause & Menopause Support
Offers insights into how hormonal changes affect the body, energy, and sleep during perimenopause and menopause, aiding in understanding hormonal drift and chronic dysregulation as it emerges.
Skin Health & Mood Changes
By providing a deeper understanding of hormonal fluctuations, Clair indirectly supports insights into related symptoms such as skin health and mood changes, which are often influenced by hormonal balance.
Physician Tip

For physicians, Clair stands out by offering continuous, objective, and non-invasive hormonal data, providing a richer and more dynamic picture than traditional episodic tests. This real-time insight can significantly aid in diagnosing and assessing treatment for various women's health conditions, including those with irregular cycles or PCOS. The ability for patients to share detailed personal hormone fluctuation data can empower more informed patient-physician conversations, potentially reducing the need for repeat blood draws and addressing historical gaps in women's health research. Clair's commitment to clinically driven development, including validation against FDA-registered tests and plans for FDA approval, positions it as a medically credible tool for proactive care.

Based on available information, Clair Health's wearable and app currently focus on providing personalized insights directly to the user. While the platform empowers patients to share their data with healthcare providers, explicit integrations with Electronic Health Record (EHR) systems or other clinical platforms are not detailed for Clair Health. Data processing occurs on the app itself, emphasizing data privacy.

Products by Clair

1 product in the directory

Clair – The AI Clinical Reference Tool
Clair
Clinical Decision Support & Reference
Clair is an AI clinical reference tool that provides healthcare teams with accurate, real-time answers to clinical questions, streamlining decisions on disease states, treatments, and drug interactions.

What the Web Says

Clair (clair.health) appears to be a company with two distinct offerings based on the search results: a financial technology platform providing earned wage access, and a women's health wearable for continuous hormone tracking. Additionally, there is a separate entity, St. Clair Health, which is a hospital system, and another, CaryHealth, that offers an AI clinical reference tool also named Clair. The financial technology platform, Clair, receives positive feedback for its ease of use and ability to provide early access to wages. The women's health wearable, also named Clair, is a newer product with discussions around its innovative approach to hormone tracking. St. Clair Health, the hospital system, has mixed reviews regarding patient care and employee experiences. CaryHealth's Clair, an AI clinical reference tool, is praised for its speed, precision, and verified sources. It is important to distinguish between these entities when evaluating reviews.

Overall: Mixed

Strengths

  • Quick and reliable access to earned wages (Clair - FinTech)
  • Intuitive and easy-to-navigate app (Clair - FinTech)
  • Transparent and reasonable fees (Clair - FinTech)
  • Seamless integration with payroll platforms like Gusto (Clair - FinTech)
  • Innovative non-invasive continuous hormone tracking (Clair - Women's Health)
  • Accurate, real-time answers to clinical questions with verified sources (Clair - CaryHealth)

Limitations

  • Occasional technical issues with the app (Clair - FinTech)
  • Advance limits can sometimes feel restrictive (Clair - FinTech)
  • Mixed patient experiences, including misdiagnoses and incorrect test results (St. Clair Health)
  • Management issues, favoritism, and understaffing reported by employees (St. Clair Health)
  • Skepticism regarding the accuracy of the wearable hormone monitor for irregular cycles or transgender individuals (Clair - Women's Health)
  • Work-life balance concerns for employees (St. Clair Health)

Based on reviews from: G2, Great Place To Worku00ae, Zippia, Reddit, Trustpilot, Indeed.com, Trend Hunter, Wellworthy, CaryHealth, Longevity.Technology, Capterra

Last updated: 2026-08-07

Videos

News, demos, and interviews about Clair.

Loading videos...

Videos load interactively. If none appear, search YouTube for Clair →

View all on YouTube

Press & Coverage

Digital Health News
Clair Health Raises $11.6 Mn to Scale Health Monitoring Wearables
Clair Health, a Virginia-based digital health startup, secured $11.6 million in funding to accelerate the launch of its noninvasive, hormone-monitoring wearable. The device aims to continuously track key reproductive hormones and provide personalized insights into women's health.
2026-07
HLTH
Clair Health Raises $11.6 Million to Develop Continuous Hormone Monitoring Wearable
Clair Health, a women's health technology company, raised $11.6 million to support the development and launch of a noninvasive wearable for continuous hormone insights. The company plans to launch its device and companion app in November 2026 and will conduct an independent clinical trial.
2026-06
TNW (The Next Web)
A 21-year-old Stanford grad just raised $11.6M to build a wearable hormone monitor that doesn't need blood - TNW
Clair Health, a San Francisco startup, secured $11.6 million in seed funding to develop a continuous, noninvasive hormone monitor for women. The company plans to ship the wristband in November as a wellness product, with FDA clearance to be pursued later.
2026-06
Longevity.Technology
Clair raises $11.6m for continuous hormone tracking - Longevity.Technology
Clair Health closed a new seed round of $11.6 million, led by Khosla Ventures, to support the November 2026 launch of its noninvasive continuous hormone monitor for women. The device will infer hormone activity using physiological signals rather than invasive sampling.
2026-06
Tech Funding News
At 21, Jenny Duan saw what Oura and WHOOP missed: women's hormones. She raised $11.6M from Khosla Ventures to track them
Clair Health, co-founded by Stanford graduates Jenny Duan and Abhinav Agarwal, raised $11.6 million in seed funding to launch a noninvasive, continuous hormone monitor for women. The device uses biosensors and biomarkers to track hormones in real-time.
2026-06
Fintech Futures
Clair Health Raises $11.6M to Build Noninvasive Continuous Hormone Monitor for Women
Clair Health secured $11.6 million in seed funding to develop a noninvasive continuous hormone monitor for women, with a planned launch in November 2026. The jewelry-inspired wrist device uses 10 biosensors and over 130 proprietary biomarkers.
2026-06
The Stanford Daily
Stanford-founded startup develops wearable for continuous hormone monitoring
Clair, a startup founded by Stanford graduates Jenny Duan and Abhinav Agarwal, is developing a wearable hormone-tracking device to provide continuous, noninvasive hormone insights for women. The company aims to address the underrepresentation of women in medical research.
2026-02
Reach Capital
Making Hormone Intelligence Visible: Why We Invested in Clair | Reach Capital
Reach Capital announced its investment in Clair Health, a company building the first continuous, non-invasive hormone-monitoring wearable. Clair aims to make hormone intelligence accessible and actionable, providing proactive care for various women's health concerns.
2026-02

Frequently Asked Questions

Clair Health offers a wrist-worn wearable that provides continuous, non-invasive insights into female hormone patterns, including estrogen, progesterone, LH, and FSH. It utilizes ten biosensors and AI to infer hormone levels from physiological signals like skin temperature, heart rate, and sleep patterns, rather than direct blood draws or urine tests.
Clair's continuous tracking helps identify fertile windows, confirm ovulation by monitoring progesterone rise, and provides insights for fertility planning. Its AI models are trained on diverse female physiology, including conditions like PCOS and anovulatory cycles, to maintain accuracy even for women with irregular periods.
Clair offers continuous hormone-linked data to help women understand changes in sleep, energy, and mood during perimenopause and menopause, where symptoms are often difficult to interpret. By tracking hormonal patterns, it provides insights into how these changes affect the body, supporting better management of symptoms.
For athletes, Clair helps optimize training and recovery decisions by providing insights into how hormonal fluctuations impact performance and resilience across different cycle phases. Beyond fertility, it aids in understanding hormonal patterns to better manage overall well-being, energy levels, metabolism, and mood.
Clair's prototype was tested on over 40 women across 127 menstrual cycles, demonstrating 94.1% accuracy in classifying cycle phases and 87% sensitivity for LH surge detection. The company plans for FDA clearance and is launching an independent clinical trial to further validate its production hardware.
The Clair wearable is expected to retail at $369, with early access pricing offered at a discount. Access to certain advanced features will require a paid subscription, though specific details for healthcare professional partnerships or bulk pricing are not explicitly detailed in the provided information.
Clair aims to provide continuous, personalized hormone information that patients can share with their healthcare providers to better understand and correlate medical issues, potentially reducing the need for repeat blood draws. While the initial release is a general wellness device, the company's goal is to close the data gap for women, enabling more informed conversations with clinicians.
Clair Health, founded by Stanford graduates Jenny Duan and Abhinav Agarwal, emerged from stealth in early 2026 and plans to launch its wearable device in late 2026. The company is positioning itself as a leader in continuous hormone monitoring for women's health, with its technology trained on diverse female physiology.

Related Companies

The Utah Medical Licensing Board is a state governmental agency responsible for regulating the licensing and practice of medical professionals within Utah. It operates under the Utah Division of Professional Licensing (DOPL), which is part of the Department of Commerce. The Board’s primary function is to ensure the health and safety of Utah citizens by […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.